Event Details
Agenda
Abstracts
Event Details
Background
More than 700 researchers have participated in NMRI workshops in the past decade, and approximately 100+ are active members. The success of the NMRI, a network that is “owned” by its members and supported by the NIDDK, begins with the dedication of senior investigators who mentor and serve as role models for junior investigators. The participation of active members and the recruitment of new members is a primary reason for the Network’s success in the past and the reason for confidence that it will continue to grow in the future.
2021 NMRI Annual Workshop Featured Speaker
Please join us on April 29, 2021 for Dr. Leon McDougle’s presentation on
“The Art & Science of COVID-19 Vaccine Dissemination”
Dr. McDougle, MD, MPH, Professor of Family Medicine with tenure and Chief Diversity Officer for the Ohio State University Wexner Medical Center, is the 121st President of the National Medical Association and Chair of the NMA COVID-19 Task Force on Vaccines and Therapeutics, member of the National Collegiate Athletic Association (NCAA) COVID-19 Medical Advisory Group, and member of NIDDK Network of Minority Research Investigators since 2008.
Travel Awards
(For the safety of our speakers and participants the NMRI Annual Workshop will be held virtually. No travel awards will be provided for the meeting.)
Agenda
Wednesday, April 28, 2021 (Times are EST)
Pre-Workshop Activities
12:00 - 2:00
- Poster Presentations
Ms. Winnie Martinez, Program Officer, Office of Minority Health Research Coordination, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
2:00 - 4:00
- Mentor/Mentee Program (Pre-registration required)
Mentors and Mentee will have an opportunity to meet during assigned time.
- Specific Aims Review (Pre-registration required)
Specific Aim Reviewer and PI will have an opportunity to meet during assigned time.
Thursday, April 29, 2021 (Times are EST)
12:00 p.m. – 12:30 p.m.
- Welcome and Introduction
Dr. Patricia Heyn, Associate Professor, University of Colorado Anschutz Medical Center
Dr. Lawrence Agodoa, Director, Office of Minority Health Research Coordination, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
12:30 p.m. – 1:20 p.m.
- Interactive Parrallel Session I (Pre-select Session)
Session 1 – K Awards Process
Dr. Jason Hoffert, Scientific Review Officer, Grants Review Branch, NIDDK
This talk will present various career development funding opportunities available to junior investigators through NIH and the NIDDK. A timeline of your application from submission to critique will also be presented.
Session 2 - R01 Awards
Dr. James Mack, Scientific Review Officer, Center for Scientific Review, NIH
This session will discuss the process from submission to critique.
Session 3 - Other Federal Funding Opportunities
Dr. Francisco Villarreal, Professor, University of California, San Diego
Dr. Mark Roltsch, Health Science Officer, US Department of Veterans Affairs
This session will discuss other federal research funding opportunities mainly those associated with the VA administration and the Department of Defense medical research program.
Session 4 - Funding on Gender Base Research & Health Disparity
Dr. Roland J. Thorpe, Jr. Professor, Department of Health, Behavior and Society, Founding Director, Program for Research on Men’s Health, Deputy Director, Hopkins Center for Health Disparities Solutions, Johns Hopkins Bloomberg School of Public Health
Dr. Wendy L. Bennett, Co-Director of the Johns Hopkins Center for Women’s Health, Sex and Gender Research; Associate Professor of Medicine, Division of General Internal Medicine
This session will discuss research funding focused on gender and or health disparity research.
Session 5 - Community and Faith Base Research Subgroup
Dr. Lynda Brown, Chief Executive Officer
Dr. Marino Bruce, Professor, University of Mississippi Medical Center
The Community and Faith-Based Research (CFBR) subgroup has two goals for this session; 1) we will poll attendees to determine interest in community-based or faith-based research within CFBR, and 2) we will discuss CFBR organizational structure, leadership, and goals for publications and grants. We only have a limited amount to time accomplish these goals, so we will use multiple communication tools to provide all attendees an opportunity to give input.
1:20 p.m. – 1:30 p.m.
1:30 p.m. – 2:20 p.m.
- Interactive Parallel Session II (Pre-select Session)
Session II allows participants the option to attend a different session.
2:20 p.m. – 2:30 p.m.
2:30 p.m. – 3:20 p.m.
- NIH Mock Study Section Parallel Sessions (Pre-select Session)
Mock Study Section - R01
Dr. Rudy Ortiz, Professor, University of California, Merced
Dr. Ann Jerkins, Scientific Review Officer, Grants Reveiw Branch, NIDDK, NIH
Mock Study Section - K Awards
Dr. Mark Lawson, Professor and Director, University of California, San Diego
Dr. Maria Davila-Bloom, Scientific Review Officer, Grants Review Branch, NIDDK
Mock Study Section - R21
Dr. Jose Romero, Associate Physiologist, Harvard Medical School
Dr. Ryan Morris, Scientific Review Officer, Grants Review Branch, NIDDK, NIH
3:20 p.m. – 3:30 p.m.
3:30 p.m. – 4:15 p.m.
- The Art & Science of COVID-19 Vaccine Dissemination
Dr. Leon McDougle, Chief Diversity Officer, Professor, The Ohio State University Wexner Medical Center
4:15 p.m. – 5:00 p.m.
- Confronting the Perils of COVID-19 with Science
COVID-19 Research Topics (Pre-Registration Required)
Breakout Session 1: Diabetes and Obesity Risk Factors in Latino Community
Dr. Absalon Gutierrez, Associate Professor of Medicine, University of Texas Health Science Center at Houston
Dr. Jose Romero, Associate Physiologist, Brigham and Women’s Hospital, Harvard Medical School
Breakout Session 2: Kidney Disease Implications
Dr. Myra Kleinpeter, Associate Professor of Clinical Medicine, Tulane University School of Medicine
Breakout Session 3: Immune and Vascular Systems as Drivers of End-Organ Damage
Dr. Francisco Villarreal, Professor, University of California, San Diego
Breakout Session 4: Addressing Health Disparities
Dr. Heather Tarleton, Associate Professor, Loyola Marymount University
Breakout Session 5: Physical Activity and Diet Protective Findings, Do we have a case?
Dr. Patricia Heyn, Associate Professor, University of Colorado Anschutz Medical Center
Dr. Leon McDougle, Chief Diversity Officer, Professor, The Ohio State University Wexner Medical Center
Friday, April 30, 2021 (Times are EST)
11:15 a.m. – 12:00 p.m.
- Introduction
Dr. Lawrence Agodoa, Director, Office of Minority Health Research Coordination, National Institute of Diabetes and Digestive and Kidney Diseases, NIH
- Welcome Remarks
Dr. Griffin Rodgers, Director, National Institute of Diabetes and Digestive and Kidney Diseases
12:00 p.m. – 1:10 p.m.
- Scientific Presentations (Presentations by Awardees)
Dr. Jose Romero, Associate Physiologist, Harvard Medical School
Basic Science - Awardee Presentation
Clinical Science - Awardee Presentation
Translational Science – Awardee Presentation
1:10 p.m. – 1:20 p.m.
1:20 p.m. – 2:20 p.m.
2:20 p.m. – 2:30 p.m.
2:30 p.m. – 3:30 p.m.
- Minority Health and Gender Scientific Research
Dr. Roland J. Thorpe, Jr. Professor, Department of Health, Behavior and Society, Founding Director, Program for Research on Men’s Health, Deputy Director, Hopkins Center for Health Disparities Solutions, Johns Hopkins Bloomberg School of Public Health
Dr. Wendy Bennett, Co-Director of the Johns Hopkins Center for Women’s Health, Sex and Gender Research, Associate Professor of Medicine, Division of General Internal Medicine
3:30 p.m. – 4:00 p.m.
4:00 p.m. – 4:50 p.m.
- Updates from the Network of Minority Health Research Investigators
Dr. Patricia Heyn, Chair, 2021 NMRI Planning Board Associate Professor, University of Colorado Anschutz Medical Center
Dr. Myra Kleinpeter, Chair, 2021 NMRI Oversight Board Associate Professor of Clinical Medicine, Tulane University School of Medicine
Dr. Bessie Young, Chair Elect, 2022 NMRI Planning Board Professor, University of Washington
Dr. Marja Hurley, Chair Elect, 2022 NMRI Oversight Board Professor of Medicine and Orthopedics, UConn Health
Dr. Marino Bruce, Co-Chair, NMRI Community and Faith Base Research Subgroup, Professor, University of Mississippi Medical Center
Dr. Shirley Blanchard, Ad Hoc Member, Oversight Board Associate Professor, Creighton University
4:50 p.m. - 5:00 p.m.
- Closing Remarks
Dr. Lawrence Agodoa, Director, Office of Minority Health Research Coordination, NIDDK
Winnie Martinez, Program Officer, Minority Health Research Coordination, NIDDK
Abstracts
Submission Deadline
March 22, 2021 (11:59 p.m. EST)
Submitting Abstracts
Abstracts can be emailed to Winnie Martinez as a Microsoft Word document by the deadline date listed above. Please put “NMRI Abstract - (Translational, Basic or Clinical)” in the subject line. Or you may upload your abstract on your registration page. Please indicate a category (Translational, Basic, or Clinical) on top right corner and follow the guidelines below.
Abstract Organization
Organize the body of the abstract as follows:
- Statement of the purpose of the study/program/project;
- Statement of the methods used;
- Summary of the results presented in sufficient detail to support the conclusion
- Statement of the conclusions reached.
Formatting Requirements
Your abstract must conform to the above guidelines, as incorrect formatting could result in disqualification.
- The abstract should be typed single-spaced, type no smaller than 10 point (12 cpi).
- Use a common font (e.g., Helvetica, Times New Roman, or Arial)
- Set the margins to the following using Microsoft Word: Top 1"; Bottom 1"; Left 1.25"; Right 1".
- Abstract should be no more than one page in length.
- The abstract’s title should be typed in CAPITAL LETTERS and should clearly represent the nature of the investigation.
- Title should be followed in lowercase letters by the author’s first and last names, degree, affiliation (if applicable), city, state, and country. Underline the primary author’s name (one primary author per abstract).
- Leave one blank line between the title and the body of the abstract, and between paragraphs.
- Do not indent paragraphs.
- Use of standard abbreviations is desirable (e.g., RBC). Use kg, gm, mg, mL, L, and %. Place a special or unusual abbreviation in parentheses after the full word the first time that it appears.
- Use numerals to indicate numbers except to begin sentences.
- Do not use subtitles (e.g., Methods, Results).
- Simple tables or graphs may be included; however, they must fit within the designated abstract space.
- The abstract file should be saved as: primary author’s last name_first word in the title (e.g., Zucker_Effects).
Poster Presentations
Poster Presentations will be held virtually. Please limit your slides to no more than 5.
- Introduction & Objectives
- Material & Methods
- Results I
- Results II
- Discussion & Conclusion
